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Abstract The N-terminal domain of laminin K4 chains
corresponds to a short rod-like structure which after recombinant
production was found to be modified by chondroitin sulfate.
Substitution occurred mainly to a single serine in its N-terminal
ASGDG sequence. A similar yet partial modification was also
demonstrated for the K4 chain present in extracts of adult mouse
tissues. Antibodies to the fragment were useful to demonstrate a
relatively high content of K4 in several tissues and for the
immunolocalization in various blood vessels, some basement
membranes and interstitial regions. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Laminins represent a large family of basement membrane
proteins and are crucial elements for the structural integrity of
these extracellular matrices as well as for mediating cell^ma-
trix interactions. They are composed of disul¢de-linked K,L,Q
chains and ¢ve K, three L and three Q chains have been iden-
ti¢ed so far [1,2]. The K chains consist of a central coiled-coil
domain II,I important for chain assembly, and have a unique
set of ¢ve globular LG modules (LG1^LG5) at the C-termi-
nus implicated in cell adhesion. Their N-terminal short arms
are composed of tandem arrays of LE modules which form
tight rod-like segments [3] and some other globular domains.
This region is particularly short in the K4 chain and consists
mainly of three LE modules [4^8]. As a consequence, laminin-
8 (K4L1Q1) and laminin-9 (K4L2Q1) [9] lack one of the three
short arms when visualized by rotary shadowing [7,10]. A
further truncation may occur through proteolytic processing
which releases the most C-terminal K4 LG4^5 modules. Cor-
responding fragments could still be detected in cell cultures
but no longer in tissues by immunostaining [11]. This could in
part explain a considerable electrophoretic heterogeneity of
K4 with bands of 190, 200, 220 and 230 kDa detected in
platelet extracts and endothelial cells by immunoblotting
with K4-speci¢c antibodies [11,12].
The laminin K4 chain is strongly expressed in a large variety
of tissues including heart, lung, muscle, embryonic kidney,
peripheral nerves and adipose tissue [4^9,11,13] and is consid-
ered to be a major component of endothelial cells and vessel
walls. Recent studies of mouse lines with K4 chain de¢ciency
underscored this interpretation by showing massive but tran-
sient hemorrhages at neonatal stages and impaired angiogen-
esis in adult mice [14]. This de¢ciency caused in addition an
improper localization of motoneuron synapses [15]. Our
understanding of the various functions of the K4 chain at
the molecular level, however, is still at the beginning. Lami-
nins containing this chain were shown to be cell-adhesive
through the binding of K6L1 and K6L4 integrins [10,12].
This very likely involves the K4LG1^3 modules and part of
the long arm rod as shown by antibody inhibition [11]. Such
or related interactions could be involved in the recruitment of
T cells across the blood^brain barrier [15]. The a⁄nity for K-
dystroglycan receptors seems, however, to be relatively low
compared to other laminin K chains [11]. The K4LG modules
also showed binding to heparin, sulfatides and ¢bulins [11]
and a particularly strong heparin binding site has been
mapped to the K4LG4 module [17]. No binding functions
have so far been identi¢ed for the short arm region of the
K4 chain. However, this region contains an SGD and several
more SG sequences which could be modi¢ed by glycosamino-
glycan attachment as shown before for perlecan [18,19].
In the present study we have prepared the N-terminal re-
gion (fragment K4IIIa) by recombinant production in mam-
malian cells and show its nearly complete substitution by
chondroitin sulfate. A partial substitution of K4 chains could
be demonstrated in tissue extracts by antibodies against
K4IIIa. These antibodies were also useful to quantitate the
K4 chain in tissue extracts and to examine tissue localizations.
2. Materials and methods
2.1. Production of recombinant proteins
An expression vector for the N-terminal region of mouse laminin
K4 chain was constructed by overlap extension PCR using the 5P and
3P primers GTCAGCTAGCCCTGTTGAATATCTGCAG and
GTGCGGAAGAATCCAGCGTC (nt 363^607) and e.end2 cell
RNA as template and GACGCTGGATTCTTCCGCAC and GT-
CACTCGAGTCAGCCTGTAGGGACTTCAAATC (nt 588^1181)
and cDNA clone M-47 [5] following standard protocols. The ¢nal
product was then inserted through NheI/XhoI restriction sites into
the episomal expression vector pCEP/Pu and used for the transfection
of human kidney 293-EBNA cells [20]. Serum-free culture medium (1 l)
was passed over a DEAE cellulose column (2.5U8 cm) equilibrated in
0.05 M Tris^HCl, pH 8.6, and eluted with a linear gradient of 0^0.6 M
NaCl (800 ml). This was followed by chromatography on a Superose
12 column (HR16/50; Amersham) equilibrated in 0.2 M ammonium
acetate, pH 6.8. A carbazole assay for uronic acids [21] was used to
identify the position of the recombinant fragment. Recombinant
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N-terminal fragments K3AIIIa (position 1^212) and K2VI/V (1^513)
from mouse laminin K3A and K2 chains were prepared and puri¢ed
by similar procedures used in previous studies [11,19]. All vectors used
were veri¢ed by sequencing.
2.2. Protein characterization
Protein samples were hydrolyzed (16 h, 110‡C) with 6 M or 3 M
HCl for the determination of protein concentrations and hexosamine
compositions, respectively, on a Biotronic LC3000 analyzer. Edman
degradation was performed on 473A or Procise sequencers following
the manufacturer’s instruction and the extent of serine substitution
estimated from the relative yield of the PTH derivative [18]. Diges-
tions with heparitinase, chondroitinase ABC (Seikagaku) and chon-
droitinase B (Sigma) were carried out as previously described [18].
Limited digestion with trypsin (4 h, 37‡C) was achieved at an en-
zyme^substrate ratio of 1:100. Complete reduction and alkylation
of proteins was performed in 6 M guanidine HCl [22]. Electrophoresis
was performed in calibrated SDS gels followed by Coomassie blue
staining.
2.3. Immunological assays
Immunization of rabbits, a⁄nity puri¢cation of antibodies, ELISA
and radioimmunoassays followed standard protocols [23]. Rabbit
antibodies against mouse laminin K4LG1^3 [11] and a rat monoclonal
antibody BE1/4 against mouse nidogen-1 [24] have been described
previously. Extraction of mouse tissues was performed by neutral
bu¡er containing 10 mM EDTA followed by the same bu¡er contain-
ing detergents and protease inhibitors [25]; the extracts were used for
radioimmunoinhibition assays speci¢c for K4IIIa. Similar inhibition
assays for mouse laminin Q1III3^5 [26] and K2VI/V (T. Sasaki, R.
Giltay, U. Talts, R. Timpl, J.F. Talts, submitted) have been described.
Detergent extracts (100 Wl) and 5 Wg puri¢ed anti-K4LG1^3 were used
for immunoprecipitation with protein A-Sepharose [27]. These precip-
itates were used without or after treatment with chondroitinase ABC
for SDS gel electrophoresis under reducing conditions followed by
immunoblotting with anti-K4LG1^3 [11]. Double immuno£uorescence
staining of tissue cryo-sections with puri¢ed rabbit anti-K4IIIa
(5 Wg/ml) and BE1/4 (10 Wg/ml) was followed by secondary Cy3
goat anti-rabbit (Jackson ImmunoResearch) and Alexa 488 goat
anti-rat IgG (Molecular Probes). Control incubations with normal
IgG gave negative results. Some double stainings were also performed
with K-bungarotoxin labeled with Texas red (Molecular Probes).
3. Results
The N-terminal short arm region of the mouse laminin K4
chain [5,7,8] consists of 265 amino acids including a 24-residue
signal peptide. This segment contains three typical disul¢de-
bonded laminin LE modules [3] (position 82^238) £anked on
each side by regions with a low cysteine content. The sequence
contains in addition ¢ve Ser-Gly pairs (26-SGD, 53-SGV, 76-
SGE, 95-SGF, 190-SGN) known from other proteins [28] to
be potential candidates for glycosaminoglycan attachment.
We have therefore prepared the entire segment as a recombi-
nant fragment K4IIIa in transfected human 293 cells which, as
shown before for perlecan domains [18,19], makes it possible
to identify glycosaminoglycan substitutions. Examination of
serum-free culture medium by SDS gel electrophoresis failed
to demonstrate a protein band of the size expected from the
sequence (30^40 kDa) even though the medium contained 4^
6 Wg/ml K4IIIa as shown by radioimmunoassay (see below).
The modi¢ed form of the recombinant fragment was there-
fore initially puri¢ed on DEAE cellulose (not shown) and
eluted as a strong uronic acid-positive peak at the end of
the gradient (0.4^0.56 M NaCl). Subsequent molecular sieve
chromatography showed a considerably size heterogeneity
(Fig. 1a) and the fragment was divided into four pools for
separate examination by SDS gel electrophoresis (Fig. 1b).
This demonstrated broad and di¡usely stained protein bands
of 200^220 kDa (pool 1), 150^200 kDa (pool 2), 60^80 kDa
(pool 3) and 50^60 kDa (pool 4) which are typical for pro-
teoglycans [18,19]. This heterogeneity was con¢rmed by deter-
mination of galactosamine contents which varied from about
80 residues (pools 1, 2) to 50 (pool 3) and 35 residues (pool 4).
All pools showed in addition the same glucosamine content
(six residues) indicating the partial modi¢cation of Asn-104
and Asn-215 which are in a typical consensus sequence for
N-glycosylation.
Digestion of the K4IIIa pools by chondroitinase ABC re-
leased a uniform set of smaller fragments consisting of a
38/40-kDa doublet band and smaller amounts of 30/33-kDa
bands (Fig. 1c). No release was observed after digestion with
chondroitinase B or heparitinase (not shown) demonstrating
that K4IIIa is exclusively modi¢ed by chondroitin sulfate side
chains. As based on the galactosamine content their molecular
mass can vary between 15 and 40 kDa, Edman degradation of
chondroitinase ABC-treated K4IIIa pools was used to localize
potential glycosaminoglycan acceptor sites since the corre-
sponding serines still contain some carbohydrate and can
therefore not be identi¢ed as such [18]. This showed for the
38- and 40-kDa bands the same single sequence 25-AXGDG-
NAFP con¢rming the predicted signal peptide cleavage site
[4^8]. Ser-26 could not be identi¢ed indicating its full occupa-
tion by chondroitin sulfate. The N-terminal sequences of the
31- and 33-kDa bands started with 55-VTLGRL and two
more fragments generated by brief trypsinization started at
positions 45 and 60, respectively. This demonstrated the pres-
Fig. 1. Molecular sieve chromatography of recombinant fragment
K4IIIa (a) and analysis by SDS gel electrophoresis under reducing
conditions (b,c). Puri¢cation on a Superose 12 column was moni-
tored for protein absorbance (solid line) and by carbazole assay for
uronic acids (dashed line) and pools 1^4 were collected as indicated.
Electrophoreses were performed prior to (b) and after (c) digestion
of pools 1^4 with chondroitinase ABC and the runs were calibrated
with reduced marker proteins (in kDa).
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ence of Ser-53 and Ser-76 indicating the lack or only minimal
occupation by chondroitin sulfate.
In order to identify similar modi¢cations in tissue forms of
K4 chain-containing laminins and to analyze their tissue con-
tents and distribution we prepared a rabbit antiserum against
the glycosaminoglycan form of K4IIIa. This antiserum showed
high titers in ELISA and radioimmunoassay and only mini-
mal cross-reaction with similar fragments from related K
chains. We also established a sensitive radioimmunoinhibition
assay which could be inhibited by K4IIIa (half-maximal at
0.4 nM) while the related N-terminal fragments of K2 and
K3 chains (K2VI/V, K3AIIIa) showed no e¡ects at more
than 100-fold higher concentrations (Fig. 2). Digestion of
K4IIIa with chondroitinase ABC did not change its inhibitory
capacity but a large loss was observed after reduction and
alkylation indicating that the antibodies recognize protein epi-
topes.
The radioimmunoassay could be also inhibited by mouse
tissue extracts showing a very similar dose^response pro¢le
compared to K4IIIa (Fig. 2). This demonstrated that the assay
will be useful for quantitation and was applied to various
adult mouse tissues which were sequentially extracted with a
neutral EDTA-containing bu¡er followed by detergents [25].
This protocol was separately shown to solubilize 70^90% of
the laminins from tissues (T. Sasaki, R. Timpl, unpublished).
The extracts were in addition examined for their content of
laminin Q1 chain (Q1III3^5 assay), which is shared by most
laminin isoforms, and K2 chain (K2VI/V assay), which is the
most prevalent laminin K chain in most tissues [2]. The data
demonstrated a variable content of K4 chain (10^65 pmol/g
wet tissue) comprising 5% (placenta) to 30% (lung, skin, stom-
ach) of the Q1 chain content (Table 1). Interestingly, some
tissues (lung, skin) contained signi¢cantly more K4 than K2
chain while in most other tissues, especially in heart and skel-
etal muscle, the K2 chain predominated.
Several tissue extracts were then used to examine the pos-
sible modi¢cation of K4 chains by chondroitin sulfate substi-
tution. The corresponding laminins were ¢rst immunoprecipi-
tated with antibodies to K4LG1^3 and then examined prior to
and after treatment with chondroitinase ABC by reducing
electrophoresis followed by immunoblotting (Fig. 3). This
demonstrated a major K4 chain band of 190^200 kDa and
one to three additional bands in the range of 210^230 kDa.
Several of these additional bands were lost or reduced in in-
tensity after digestion indicating their substitution by chon-
droitin sulfate. The blot also demonstrated some larger K4
bands of about 600 kDa or higher molecular mass suggesting
covalent cross-linking of the laminin chains by non-reducible
Fig. 2. Radioimmunoinhibition assay for laminin fragment K4IIIa.
The assay consisted of 1 ng 125I-labeled K4IIIa and a constant
amount of a rabbit antiserum against K4IIIa. Inhibitors used were
mouse laminin fragments K4IIIa, prior to (b) and after chondroiti-
nase treatment (8) or reduction and alkylation (S), K3AIIIa (F)
and K2VI/V (R). EDTA extracts from adult mouse heart (a) and
intestine (E) were used at the dilution shown on top.
Table 1
Contents of laminin Q1, K2 and K4 chains in tissue extracts from adult mice determined by speci¢c radioimmunoinhibition assays
Tissue Assays for
Q1III3^5 (pmol/g wet tissue) K2VI/V (pmol/g wet tissue) K4IIIa (pmol/g wet tissue)
Heart 567 281 47
Lung 225 27 65
Skeletal muscle 133 84 13
Skin 31 11 11
Placenta 510 10 23
Intestine 97 18 33
Stomach 168 98 45
Kidney 64 21 10
Tissues were extracted sequentially with neutral bu¡er containing EDTA followed by detergents and the sum of both extracts is recorded. Pla-
centa is particularly rich in K1 chain (484 pmol/g).
Fig. 3. Immunoblot detection of laminin K4 chain in tissue extracts
and e¡ects of chondroitinase digestion. Laminins containing K4
chains were immunoprecipitated from detergent extracts of mouse
skeletal muscle (1), placenta (2), heart (3) and lung (4) and exam-
ined prior to (3) and after (+) digestion with chondroitinase ABC.
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bonds. A few of these bands were also changed after chon-
droitinase ABC digestion indicating their substitution.
Previous studies with antibodies against recombinant C-ter-
minal fragments of laminin K4 showed a clear immunostain-
ing for the K4LG1^3 structure while the most C-terminal
K4LG4^5 could not be detected in tissues [11]. We have there-
fore also used a⁄nity-puri¢ed antibodies against K4IIIa for
tissue immuno£uorescence and compared them in double
staining with the ubiquitous basement membrane protein ni-
dogen-1 (Fig. 4). This showed that in neonatal skin nidogen
staining was restricted to the basement membrane zones at the
dermal^epidermal junction and around hair follicles and to
some capillaries and larger vessels while the reaction with
dermal tissue was rather weak. The K4 chain could, however,
be primarily detected around these vessels and as large dermal
deposits between the hair follicles with only little overlap with
their basement membranes. A restriction of the K4 chain to
small and some larger vessels and bronchial stroma was also
found in embryonic lung and only little staining was observed
for alveolar basement membranes. The latter could be clearly
stained for nidogen which was also present in most of the
vessel walls. In heart and muscle the K4 chain was also a
typical component of capillaries and of the perineurium. In
skeletal muscle it included a few synaptic regions as demon-
strated by double staining with K-bungarotoxin (not shown).
Nidogen was also found in these locations but in addition in
the basement membranes around myocytes and cardiomyo-
cytes. A similar di¡erence was detected in kidney with nido-
gen being present in tubular and glomerular basement mem-
branes and some vessel walls. A much stronger staining of
various vessels was again observed with antibodies against
K4IIIa which also reacted with some glomerular regions and
tubular basement membranes in a segmental fashion (Fig. 4).
4. Discussion
A mature form of the laminin K4 chain has recently been
shown to have lost the most C-terminal K4LG4^5 modules
which could no longer be detected in adult tissues [11]. A
similar processing has so far been known only for the laminin
K3A chain and included as a second step also the release of
the N-terminal segment K3AIIIa [29]. This segment has a
similar size and modular structure as the N-terminal domain
(K4IIIa) of the laminin K4 chain [1,2], raising the interesting
question whether it is also removed by proteolytic cleavage.
We therefore prepared recombinant K4IIIa in order to obtain
antibodies for these analyses and to examine in addition its
posttranslational modi¢cations as suggested from some se-
quence peculiarities. The data showed the persistence of the
K4IIIa segment in tissues and its e⁄cient substitution by
Fig. 4. Double immuno£uorescence staining of mouse tissues with rabbit antibodies against K4IIIa and rat monoclonal antibody against nido-
gen-1 (Nd1). Tissues used were neonatal skin, embryonic lung (day 18) and adult heart, muscle and kidney. The bar (skin) indicates 50 Wm for
all tissues.
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chondroitin sulfate, a modi¢cation not known before for oth-
er laminin chains.
The nearly complete modi¢cation of recombinant K4IIIa
facilitated its puri¢cation and demonstrated a distinct size
heterogeneity (15^40 kDa) for the chondroitin sulfate chains
attached. A single SGD sequence close to the N-terminus
represents the major acceptor site while another candidate
SGE sequence seems to be not or only minimally modi¢ed.
Three SGD sequences and a single SGG were shown to be the
major glycosaminoglycan attachment sites in the basement
membrane proteoglycan perlecan but are usually modi¢ed
by heparan sulfate [18,19,30]. The lack of modi¢cation of
SGE in the recombinant K4 chain fragment may re£ect the
lack of adjacent controlling sequences as shown for perlecan
[30]. Alternatively, since this SGE is located in an LE module-
type disul¢de-bridged d-loop known to make tight intermod-
ular contacts in tandem arrays of such modules [3], this could
impose strong constraints on accessibility. A similar yet par-
tial modi¢cation was also shown for the K4 chains obtained
from several tissues indicating a biological function but also
tissue variability. Laminins containing K4 chains were also
obtained from platelets [12], some cultured cells [7,11] and
as a recombinant product [10], and showed in part a similar
electrophoretic heterogeneity. It will be of interest to examine
to which extent chondroitin sulfate modi¢cation accounts for
this.
Chondroitin sulfate proteoglycans are prominent compo-
nents of cartilage and many other interstitial matrices includ-
ing in particular the families of lecticans/hyalectans and some
leucine-rich repeat proteoglycans [31,32]. They have also been
identi¢ed as cellular receptors including syndecans and NG2
[33], as a minor perlecan variant and another basement mem-
brane proteoglycan bamacan [18,34]. Our data now add lam-
inins-8 and -9 as further members to these components. Com-
pared to heparan sulfates [31,33] very little is known about the
molecular functions of chondroitin sulfates. They certainly
endow their core proteins with a strong polyanionic character
which could compartmentalize and in£uence supramolecular
organization in extracellular matrices [35]. They also play a
major role in the extracellular brain matrix and could be in-
volved in nerve guidance [32]. This now remains to be exam-
ined by the identi¢cation of potential ligands for the K4IIIa
segment.
Rabbit antisera against C-terminal LG modules of the K4
chain were previously shown to be useful for immunoblotting
and immunostaining of cells and tissues [11]. These antigenic
fragments could, however, not be used for radioimmunoas-
says apparently due to a high sensitivity for radiation damage
(unpublished). This was not the case with fragment K4IIIa,
which made it possible to establish a sensitive and reprodu-
cible inhibition assay for the quantitation of the K4 chain in
tissue extracts. This revealed particularly high levels in lung,
heart, stomach, placenta, intestine, muscle and skin and ac-
counted for 5^30% of the laminin Q1 chain contents in these
extracts. The data are consistent with a comparably high ex-
pression of K4 mRNA in these tissues described previously [4^
9,13]. The antibodies against K4IIIa were also suitable for
immuno£uorescence analysis of tissues with staining patterns
similar to those described for anti-K4LG1^3 [11] and also with
some di¡erences, with antibodies against K4 domain I,II fu-
sion proteins [8,9]. In the heart and skeletal muscle K4 stain-
ing was restricted to capillary walls and perineural basement
membranes and some synapses while basement membrane
zones where positive for nidogen-1 but not for K4. Capillary
staining for K4 chain was also found in skin, lung and kidney
(Fig. 4) and has been described for brain [16]. The corre-
sponding laminins are very likely produced by endothelial
cells as shown by in situ hybridization [7] and in cultured cells
[7,11]. They are, however, not necessarily deposited in the
endothelial basement membranes but in some adjacent regions
as indicated by immunogold staining [11].
The deposition of K4 chain laminins to interstitial regions
close to basement membranes was also suggested by the stain-
ing patterns of some other tissues. This was clearly evident for
skin which showed a distinct staining of the dermis between
hair follicles but not around their basement membranes which
is in agreement with K4 in situ hybridization of skin mesen-
chymal cells [7]. There was also a lack of staining of alveolar
basement membranes which are, however, surrounded by
many K4 chain-positive capillaries. Typical basement mem-
branes such as in renal glomeruli and tubules appeared also
not or only segmentally stained. A de¢nitive proof of these
indications will now require immunogold staining with the
antibodies described here and previously. This may re£ect
the peculiar structure of the N-terminal region of the K4 chain
which lacks an LN module known to be important in other K
chains for the polymerization of laminins into non-covalent
networks within basement membranes [36,37]. It also suggests
that laminins-8 and -9 participate in di¡erent supramolecular
assemblies when deposited in non-basement membrane re-
gions which also, as shown here for skin, are stained only
weakly for nidogen-1, a major ligand of the laminin Q1 chain
[26], which is needed for the stabilization of such networks.
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